Psychiatrist

A New White Paper Lays Out How To Incorporate Psychedelic Therapies into the Mainstream Health System

This white paper outlines the current, challenges, and potential solutions for incorporating psychedelics into mainstream medical practice.

Read More

Johnson & Johnson’s Spravato Surges Toward Blockbuster Status

Johnson & Johnson's depression nasal spray Spravato continues its impressive growth trajectory, generating $414 million in Q2 2025 revenue.

Read More

Are Psychedelic Diagnoses Freeing Us? Or Caging Us?

A podcast with Gabor Maté convinced me I have ADHD. As I learned more, my symptoms worsened. And I wondered:

Read More

Congressional Psychedelics Report Card: Who Supports and Opposes Legalization

Knowing which members of Congress will advance or block psychedelic medicine helps advocates know where to focus their energy.

Read More

Federal Judge Orders Utah Police to Return Psychedelic Mushrooms to Religious Group

A federal judge has ordered Utah police to return psychedelic mushrooms they seized from members of a religious group.

Read More

7 Hidden Revenue Leaks Killing Your Ketamine Practice’s Profitability

These revenue leaks often remain invisible until they accumulate into thousands of lost income each month. Let's help you fix

Read More

How Can You Tell If A Psychedelic Integration Therapist is Trustworthy

A good psychedelic integration therapist possesses several key qualities and qualifications. Here's some to look for.

Read More

Why Timing Matters: The Science Behind Scheduling Psychotherapy After Ketamine

New insights: Should psychotherapy happen during the ketamine session, immediately after, or the following day?

Read More

A New Study Reveals How Psychedelics Impact Intimacy and Sexual Expression

In the first study of its kind, nearly 600 individuals shared how psychedelics impact intimacy and sexual expression.

Read More

Democratic Congressman Says Trump Admin Signals Revolutionary Shift on Drug Policy Reform

Democratic Congressman Lou Correa believes the Trump administration presents an unprecedented opportunity to transform American drug policy.

Read More

Explore Psychedelic Therapy Regions